Form 8-K - Current report:
SEC Accession No. 0001104659-20-081228
Filing Date
2020-07-06
Accepted
2020-07-06 16:17:33
Documents
14
Period of Report
2020-07-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2024180d1_8k.htm   iXBRL 8-K 26507
2 EXHIBIT 99.1 tm2024180d1_ex99-1.htm EX-99.1 18933
6 GRAPHIC tm2024180d1_ex99-1img01.jpg GRAPHIC 3884
  Complete submission text file 0001104659-20-081228.txt   233554

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pcrx-20200706.xsd EX-101.SCH 3180
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pcrx-20200706_lab.xml EX-101.LAB 34591
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pcrx-20200706_pre.xml EX-101.PRE 22706
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2024180d1_8k_htm.xml XML 5279
Mailing Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054 973-254-3560
Pacira BioSciences, Inc. (Filer) CIK: 0001396814 (see all company filings)

IRS No.: 510619477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35060 | Film No.: 201013707
SIC: 2834 Pharmaceutical Preparations